A galactose-functionalized dendritic siRNA-nanovector to potentiate hepatitis C inhibition in liver cells

Nanoscale, 2015, 7,16921-16931
DOI: 10.1039/C5NR02898A, Paper

Open Access

  This article is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported Licence.

Abirami Lakshminarayanan, B. Uma Reddy, Nallani Raghav, Vijay Kumar Ravi, Anuj Kumar, Prabal K. Maiti, A. K. Sood, N. Jayaraman, Saumitra Das
A multidisciplinary approach providing 'proof-of-concept' for liver-targeted delivery of siRNA using dendritic galactoside vector to combat HCV infection.
The content of this RSS Feed (c) The Royal Society of Chemistry

Click for full article